Evommune's Innovative Phase 2 Trial for EVO301 Tackles Atopic Dermatitis Challenges Evommune has initiated a pivotal Phase 2 clinical trial for EVO301, a targeted therapy for adult patients suffering from atopic dermatitis. This innovative treatment aims to address unmet needs in effective dermatological care.

Evommune's Innovative Phase 2 Trial for EVO301 Tackles Atopic Dermatitis Challenges #United_States #Palo_Alto #Atopic_Dermatitis #Evommune #EVO301